Literature DB >> 23220547

Differential effects of 1,25-dihydroxyvitamin D on mineralisation and differentiation in two different types of osteoblast-like cultures.

D Yang1, G J Atkins, A G Turner, P H Anderson, H A Morris.   

Abstract

In osteoblast cultures, 1,25-dihydroxyvitamin D (1,25D) has been shown to play either catabolic or anabolic roles on differentiation and mineralisation. We have employed osteoblast-like cells extracted from neonatal mouse calvariae and cells derived from juvenile mouse long bones to compare the biological effects of 1,25D on differentiation and mineralisation in vitro. 1,25D exerts differential effects on osteoblast-like cells depending on their stage of maturation and possibly their skeletal origin. This article is part of a Special Issue entitled 'Vitamin D Workshop'.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23220547     DOI: 10.1016/j.jsbmb.2012.11.016

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  7 in total

Review 1.  Vitamin D Activity and Metabolism in Bone.

Authors:  Paul H Anderson
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

2.  Vitamin D endocrine system and osteoblasts.

Authors:  Marjolein van Driel; Johannes P T M van Leeuwen
Journal:  Bonekey Rep       Date:  2014-02-05

Review 3.  Nanoparticulate drug delivery platforms for advancing bone infection therapies.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  Expert Opin Drug Deliv       Date:  2014-08-11       Impact factor: 6.648

Review 4.  Vitamin D activities for health outcomes.

Authors:  Howard A Morris
Journal:  Ann Lab Med       Date:  2014-04-08       Impact factor: 3.464

5.  Cells Derived from Human Long Bone Appear More Differentiated and More Actively Stimulate Osteoclastogenesis Compared to Alveolar Bone-Derived Cells.

Authors:  Cindy Kelder; Cornelis J Kleverlaan; Marjolijn Gilijamse; Astrid D Bakker; Teun J de Vries
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

6.  Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models.

Authors:  Julia Paton-Hough; Simon Tazzyman; Holly Evans; Darren Lath; Jenny M Down; Alanna C Green; John A Snowden; Andrew D Chantry; Michelle A Lawson
Journal:  J Bone Miner Res       Date:  2018-11-26       Impact factor: 6.741

7.  Super pharmacological levels of calcitriol (1,25-(OH)2D3) inhibits mineral deposition and decreases cell proliferation in a strain dependent manner in chicken mesenchymal stem cells undergoing osteogenic differentiation in vitro.

Authors:  Vivek V Pande; Kapil C Chousalkar; Marie S Bhanugopan; Jane C Quinn
Journal:  Poult Sci       Date:  2015-11       Impact factor: 3.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.